Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: J Alzheimers Dis. 2017;57(4):1049–1069. doi: 10.3233/JAD-161118

Table 1.

FDA Approved AChEIs and NMDA antagonist in various stages of Alzheimer’s disease

Drug Name Brand Name Applicable Stages of AD FDA Approved Year
Donepezil (AChE Inhibitor) Aricept All 1996
Galantamine (AChE Inhibitor) Razadyne Mild AD to Moderate AD 2001
Rivastigmine (AChE inhibitor) Namenda Moderate AD to Severe AD 2003
Memantine (NMDA Antagonist) Exelon All 2000
Donepezil + Memantine Namzaric Moderate AD to Severe AD 2014

Adapted from Alz.org